OLIVIER DOULIERYIn this photo illustration, a woman looks at an abortion pill displayed on a smartphone on May 8, 2020, in Arlington, Virginia. The FDA temporarily lifted restrictions on the abortion pill in April due to the COVID pandemic prompting more widespread availability of chemical abortions.
They highlight serious concerns with at-home abortions and question the FDA’s reporting system.